CUSTOMFLEX® ARTIFICIALIRIS receives Transitional Pass‐through Payment Status
CMS grants pass‐through payment status to the first and only FDA‐approved iris prosthesis, allowing greater access for patients
CINCINNATI, Ohio -- VEO Ophthalmics, LLC, today announced that the CUSTOMFLEX® ARTIFICIALIRIS has been approved by the Center for Medicare and Medicaid Services (CMS) for transitional pass‐through payment status, effective January 1, 2020. The HCPCS code for the CUSTOMFLEX® ARTIFICIALIRIS that is associated with pass‐through payment is: C1839 Iris prosthesis.
The approval by CMS for transitional pass‐through payment was under the new alternative pathway for Breakthrough devices. Ron Gilliland, President and CEO of VEO Ophthalmics stated, “Since receiving FDA approval, the CUSTOMFLEX® ARTIFICIALIRIS has helped many patients suffering from symptomatic aniridia. The decision by CMS to grant pass‐through payment status will now make this unique technology available to more patients in the U.S.”
The CUSTOMFLEX® ARTIFICIALIRIS is the only iris prosthesis available in the United States, receiving FDA approval on May 30, 2018 for use in children and adults for the treatment of iris defects resulting from congenital aniridia, acquired defects or other conditions associated with a completely or partially missing or damaged iris.
People may have a damaged or missing iris from birth or as a result of ocular injuries or other trauma, disease, or surgery. They struggle to cope with symptoms related to the eye’s inability to control the level of incoming light, including light sensitivity, glare, halos, reading difficulty, and problems with night driving. Many face above‐average risk of glaucoma and cataract formation as well.
About VEO Ophthalmics
Located in Cincinnati, Ohio, VEO Ophthalmics, LLC, is a developer and distributor of ophthalmic surgical technologies. VEO focuses on improving patient care by partnering with leading ophthalmic surgeons to develop innovative tools for today’s challenging surgical environment. Close relationships with ophthalmic healthcare customers and business partners help VEO ensure that its products and service experience meet the highest standards.
To learn more, visit VEO at www.veo‐ophthalmics.com.
-
Most popular related searches
Customflex Artificialiris - Custom-Made Implant to Treataniridia or Other Iris Defects
Related news
-
IFEMA MADRID will host the Congress of the European Association for Cranio Maxillo Facial Surgery in the Palacio Municipal
This biennial congress comes to Madrid as the Spanish Professor Julio Acero occupies the Presidency of the Association, and it expects to host more than 2.000 attendees from 70 countries. This edition will mean the return to the face-to-face format after the last appointment of the Congress, celebrated in Munich in 2018, and the virtual edition celebrated last summer after the impossibility of holding it in person in Paris in 2020. IFEMA MADRID continues working for the reactivation of the MICE sector in...
-
Artugen Announces Five Abstracts Published in the 30th ECCMID Abstract Book
Clostridioides difficile infection (CDI) causes the most common healthcare-associated infections in the United States and the most frequent hospital-acquired intestinal infection in Europe and worldwide. The prevalence of C. difficile outbreaks since the early 2000s has resulted in higher morbidity and mortality along with increasing medical costs throughout the world. Without effective antibiotics and therapeutics for the prevention and treatment of infections, many of the achievements of modern medicine such...
-
Diaphragm Pacemaker for Teen Featured on WSB-TV Atlanta
Fourteen year-old Sedarius was recently featured on WSB-TV Atlanta as the first pediatric patient to receive surgery to implant a diaphragm pacemaker in the state of Georgia. Sedarius was diagnosed with CCHS when he was eight years old, and required a tracheotomy and ventilator to breathe while he slept. The Avery Breathing Pacemaker will allow him to breathe without the need for a trach or ventilator and help improve his quality of life. He was able to return home within a few days, and it is expected that he...
-
Christie Medical Holdings, Inc. Partners with DO-PA A.S. for Turkey Distribution
As the leader in vein visualization technology throughout the world, Christie’s high-quality, made-in-the USA, VeinViewer®Vision2 and VeinViewer® Flex, continue to provide customers with improved clinical outcomes such as increasing 1st stick success, decreasing medically not required PICC lines and enhancing patient satisfaction. We are committed to the continued growth of VeinViewer® as a standard of care and are excited to partner with DO-PA Inc. as our authorized distributor for Turkey.DO-PA...
-
Outlook on the Medical Ceramics Global Market to 2026 - Identify Key Drivers and Challenges
According to Fast. MR research the report titled Global Medical Ceramics Market provides comprehensive information regarding influential factors. Data included in the report has been curated by our team of industry experts, considering relevant information about the market. This report discusses the growth and trends of various regions and segments of the market. Information such as market drivers, restraints, opportunities, trends, gross revenue, average product/service price, and market share of major players...
Customer comments
No comments were found for CUSTOMFLEX® ARTIFICIALIRIS receives Transitional Pass‐through Payment Status. Be the first to comment!